Key Issues
Introduction
2.1
While the expansion of the screening programs for bowel and cervical
cancer has received widespread support, the establishment of the Register to
support this has caused some public comment. This chapter outlines the key
issues arising from evidence to the committee's inquiry.
Public health and cancer prevention
2.2
The committee recognises the overwhelming support from stakeholders for
the new National Bowel Cancer Screening Program (NBCSP) and renewed National
Cervical Screening Program (NCSP), given their important role in public health
in Australia.
2.3
The two cancer types included in the National Cancer Screening Program –
bowel and cervical – present significant health risks to Australians and
therefore pose substantial challenges from a public health perspective. The
improved screening programs, supported by the Register, will address these
challenges and save the lives of hundreds of Australians every year.
2.4
The School of Public Health and Preventative Medicine at Monash
University noted the significance of the Register:
Screening is one of the most effect ways of reducing the
incidence of cancer in our community. At a time when treatment options for many
cancers are limited and increasingly expensive, the role of screening has an
increasingly important role to play.[1]
2.5
Similarly, the Victorian Cytology Service (VCS) – a not-for-profit
health‑promotion charity which has operated cervical cancer screening
registers – argued that the Register will play a vital role in supporting the
two screening programs:
The role of screening registers has never been more critical
than in this time of transition. This is of particular importance in the
current time period as the National Cervical Screening Program, which has
proven so successful over the past 25 years, is due to transition to a new
screening method, age group and screening frequency ('Renewal') on 1 May 2017.
Ensuring that women with cervical pre-cancers and cancers are tested and
managed properly during the transition from the current program to the new program
is vital, as is a strong and effective registry infrastructure to closely
monitor and evaluate the new program in real time. Similarly, the National
Bowel Cancer Screening Program is expanding to be offered to more Australians
more frequently, also requiring effective and increasingly efficient registry
support.[2]
National Bowel Cancer Screening
Program
2.6
Bowel cancer is the second most common cause of cancer deaths in
Australia, responsible for approximately 4 000 deaths per year. Australia has
one of the highest rates of bowel cancer in the world.[3]
2.7
The expanded NBCSP encourages every Australian aged between 50 and 74 to
undertake an at-home screening test every two years. The Department of Health
(the department) predicts that this will prevent 300-500 deaths per year.[4]
2.8
Cancer Council Australia noted that current participation in the NBCSP is
37% and that expansion of the program could see a rise to 60% participation by
2020. This in turn would prevent 84 000 premature bowel cancer deaths by 2040.
As Cancer Council Australia argued:
... evidence show[s] that optimal bowel cancer screening (apart
from tobacco control) is the single most effective intervention available to
the Australian Government to reduce cancer death and disease burden.[5]
National Cervical Screening Program
2.9
Cervical cancer causes 250 deaths per year in Australia. While it is
considered one of the most preventable forms of cancer, 80 per cent of women
diagnosed with cervical cancer had either never been screened or were not
regularly screened prior to diagnosis.[6]
2.10
While the NBCSP focuses on expanding coverage of the screening test, the
renewed NCSP takes advantage of medical advances. The previous program was
based on a two-yearly Pap smear test; but from 2017 will be based on the Human
Papillomavirus (HPV) screening test, conducted every five years. This change
was based on the recommendation of the Medical Services Advisory Committee.[7]
2.11
Currently, the NCSP is based on separate registers in each of the eight
states and territories. One function of the renewed NCSP will be consolidating
those registers into one Register, as each of the states and territories opts
into the national Register.
Data privacy
2.12
A key concern for several stakeholders was that of data security and
privacy for the personal information to be contained within the Register. The
committee heard that concerns about data security and privacy may affect
people's confidence in the Register and therefore its success.
2.13
For instance, the Menzies School of Health Research noted that the
public –and particularly Aboriginal and Torres Strait Islander people – would
need to be assured that their personal information was secure to encourage
participation in the Programs.[8]
2.14
Similarly, Bowel Cancer Australia referred to their own research which
reveals high levels of reluctance to discuss the disease or take action
including screening. They argued:
Layering privacy concerns for participants and patients on
top of a disease with a considerable stigma can undermine confidence in the
Program and ultimately its life-saving potential. We therefore need to strike
the right balance between participant and patient privacy and population
screening.[9]
2.15
A key concern is that people's data must not only be secure but seen to
be secure if the Register is to succeed.
2.16
In response to such concerns, the department pointed out that Section
95B of the Privacy Act 1988 (the Privacy Act) requires external service
providers – such as Telstra Health in this instance – to abide by the same
standards as the contracting agency. Therefore, the department gave evidence
that the contract between the department and Telstra Health imposes Commonwealth-standard
privacy obligations on the latter. Included in these obligations are
requirements that Telstra Health:
- build and operate the Register in accordance with
Commonwealth cybersecurity guidelines for new ICT infrastructure, taking into
consideration sensitivity and classification of the information it stores;
- at all times comply with and adhere to the stringent
controls of the Commonwealth Protective Security Policy Framework (PSPF) which
sets out mandatory requirements to:
- manage security risks to their
people, information and assets;
- provide assurance to the
government and the public that official resources and information provided to
the Register are safeguarded; and
- incorporate protective security
into the culture of the Register; and
- at all times, comply with the Information Security Manual
(ISM) and the National Identity Security Strategy.[10]
2.17
Telstra Health specified their process for assuring data security,
noting its compliance with the Australian Government's Protective Security
Policy Framework. This includes certification through the Australian Signals
Directorate (ASD) assessment program and implementation of a continuous review
and assessment program to ensure ongoing protection of information, constant
auditing of access to the Register,[11]
alongside a requirement that all personnel with access to the Register have
security clearance and are bound by confidentiality clauses:
The Register will follow the same three layered accreditation
process that is used for all Australian Government solutions, including My
Health Record. The process includes an audit of the solution architecture and
controls, and certification that the controls have been implemented and are
operating effectively, by an independent Australian Government certified
auditor through the Australian Signals Directorate assessment program.
This accreditation and assessment process will provide
independent assurance that appropriate and effective security controls have
been implemented and operating to effectively process, store and transmit
sensitive health information. It also provides assurance that a continuous
review and assessment program has been implemented to ensure the ongoing
protection of information.
All Telstra personnel who are involved in managing or
operating the Register are bound by strict confidentiality undertakings. In
addition, Telstra personnel who have access to or are likely to have access to
the Register's data must possess appropriate security clearances.[12]
2.18
Telstra Health also confirmed that all data, by requirement, will be
stored in Australia.[13]
2.19
Pathology Australia noted that, while data privacy is an important
consideration:
We believe this legislation puts in place the necessary
patient privacy and confidentiality mechanisms that are seen in other parts of
the public – private partnership that Australia's healthcare system is built
on.[14]
2.20
Other witnesses, such as Cancer Council Australia, argued that privacy
and data issues should not obscure the Bills' function of establishing a
Register with an important role in Australia's public health:
Concerns about issues such as privacy are often raised when a
major public health initiative, underpinned by the management of
population-level health data, is introduced or reformed. While such concerns
might in some cases be in the public interest, the core priority of any
Parliament should be the saving or extending of its constituents' lives. To
this end, concerns about the bills should not have a flow-on effect of delaying
the advancement of the NBCSP or the Renewal.[15]
2.21
The committee also heard evidence about the reporting of breaches of the
security of data. Telstra Health's contract obliges them to report data breaches
to the department, and prevents reporting data breaches to affected individuals.[16]
However Telstra Health further noted that broader Telstra practice, which is
also in line with a separate piece of legislation currently under the
Attorney-General's consideration, mandates the notification of affected
individuals.[17]
2.22
The committee notes the high standards of data security under which
Telstra Health are obliged to maintain the Register. While agreeing with
witnesses that the security of personal medical information is of the utmost
importance, the committee notes assurances from both the department as the
responsible agency and Telstra Health that they as the operator have put in
place the highest possible security standards.
Timing
2.23
Several submitters emphasised the importance of the Bills' passage,
given that delays in the passage of the enabling legislation would cause delays
in the roll-out of the screening programs from May 2017. The department's
submission noted that:
Sufficient lead time is required for data migration, merging,
de-duplication, system testing and quality assurance processes prior to
commencement of the Register. However, with the lapsing of the NCSR [National
Cancer Screening Register] Legislation in May 2016, the lead time has been
reduced by approximately five months. Implementation of the Register is
reaching its critical point for meeting the go live date of the Register on 20
March 2017 for the NBCSP and the commencement of the renewed NCSP on 1 May
2017.[18]
2.24
Since the existing state registers are not equipped to handle the new
NCSP, a delay in the Register's establishment would result in a late
implementation of the new NCSP. The NBCSP would incur additional costs by
continuing in its current form as managed by the Department of Human Services.[19]
2.25
Cancer Council Australia expressed the concern that:
Delays to the passage of the bills could delay essential
program improvements needed to increase participation, such as an enhanced screening
pathway and extensions to the screening age cohort (scheduled to take effect
from 1 January 2017). Moreover, the history of the NBCSP shows that exaggerated
concerns about any aspect of its integrity discourages participation –
compounded by an overall lack of bowel cancer awareness.[20]
2.26
Similarly, the Royal College of Pathologists in Australia argued that
'time is of the essence' in the passage of the Bills and noted that 'there may
be health consequences for Australian patients if there are disconnects during
the crucial transition phase from the current to the future program'.[21]
2.27
The committee sought clarification regarding the reason why the department's
contract with Telstra Health had been finalised before the enabling legislation
had been passed. Ms Bobbi Campbell, representing the department, explained that
the amount of work required to establish the Register would mean there would be
significant delays in implementing the programs if the contracted operator
could not begin work until after the legislation had been passed:
That would be an issue in terms of migration of the data.
That would be an issue in terms of actually getting to the deadline that we
need to get to. Contracts for IT require quite a lot of build, design and
specification. There is a big process involved in essentially getting up to
speed so that the service provider can be in a position to be able to then
migrate data and provide the register. Generally speaking, Commonwealth
standard contracts have provisions in place which allow contracts to have this
necessary build process and build milestone and also allow flexibility for
those sorts of contracts to be able to be varied, amended or even terminated
should they need to be terminated.
[...]
Waiting for the legislation to be passed for the contract to
be signed would have significantly delayed the implementation of the register.[22]
2.28
In addition to that concern, several witnesses noted that the sector has
anticipated the change in screening methods, since the new test has a much
lower level of labour intensity. As a result, the workforce no longer exists to
continue supporting the current program. Pathology Australia noted that the
industry has been preparing for the transition from Pap smear tests to the new
HPV test for the past two years. As a consequence, many cytologists previously
performing Pap smear tests have moved to alternative careers and therefore the
workforce 'no longer has the ability to adequately support the current
program'.[23]
2.29
This concern was also noted by Professor Annabelle Farnsworth, Director
of Douglass Hanly Moir Pathology, providers of the largest cervical cancer
screening service in Australia. Professor Farnsworth argued that: 'It needs to
be clearly understood that the remaining workforce will not have the capacity
to support the current program beyond the proposed start date of the Renewal'.[24]
2.30
The committee notes the serious concerns stakeholders have raised
regarding potential delays to the passage of the Bills and the effects those
would have on the roll-out of the screening programs. The committee concurs that
the Bills should be passed expeditiously.
Contract with Telstra Health
2.31
A key area of interest for many submitters and witnesses to this inquiry
was the department's contract with Telstra Health, a commercial, for-profit
operator, to manage the Register.
2.32
Of particular concern for some witnesses was that Telstra Health may
have conflicts of interest between its obligation to resource and operate the
Register to the necessary standards and its duties to its shareholders to run
its business profitably. For instance, public health academic Professor Bruce
Armstrong argued in his submission:
It is so far unprecedented, to my knowledge, that the
contract for provision and management of any screening register in Australia
has been awarded to a stock-market-listed public corporation. Invariably such
registers have been provided, managed or both by a directly government
controlled entity or by a not-for-profit, non-government organisation with a
primary interest in cancer control. I believe that this has been the case
because of the perception that the operations of these entities would be
largely, if not completely, free of conflict between the public interest in the
registers' operations and any private interest the managing entities might
have.[25]
2.33
When asked about this at the committee's public hearing in Sydney on 29
September, Telstra Health Chief Executive Officer, Mr Shane Solomon, responded
that it is in the best interests of Telstra Health's shareholders for the
Register to operate without failures or compromises:
I would have to say that I do not see the difference, because
our responsibility to our shareholders—and there are many in Australia—is to
provide these sorts of services. The net effect of any of these kinds of
breaches, for example, both legislatively and contractually, would adversely affect
our shareholders. I think Telstra has a very strong view around serving
customers and that is the best way to serve shareholders. The Commonwealth is our
customer here.[26]
2.34
The School of Public Health and Preventative Medicine at Monash
University also supported Telstra Health's contract to operate the Register,
noting that the complexity of the system required would be 'well beyond the
capacity of any academic institution'.[27]
2.35
Of the process for forming the contract with Telstra Health, the department
noted:
The process for identifying a suitable Register Operator was
undertaken as an open competitive process with rigorous checks and balances in
accordance with the [Commonwealth Procurement Rules], to ensure the Register is
delivered on time, within budget and to a very high standard. The Services
Agreement between the Commonwealth and Telstra Health provides the operational
requirements for Telstra Health as the service provider for the Register,
including contractual obligations for operator personnel to protect the ICT
infrastructure and personal information held in the Register.[28]
2.36
The committee notes the department's assurances about the procurement
process and Telstra Health's capacity to operate the Register. Telstra Health
is a standalone business arm of Telstra and won a competitive tender process to
operate the Register.
Recommendations from the Office of the Australian Information Commissioner
2.37
Noting that data privacy and security was one of the main issues raised
by submitters and witnesses, the committee took particular interest in the
recommendations made by the Office of the Australian Information Commissioner
(OAIC) in its submission and evidence at the public hearing. The OAIC made a
series of specific recommendations for amendments to improve the Bills. This
section outlines those suggestions.
Relationship to Privacy Act
2.38
In its submission, the OAIC noted that there may be an unintentional
bypassing of the requirements of the Privacy Act 1988 (Privacy Act) relating
to the use of data held in the Register for the use of researchers. The OAIC
therefore recommended that the Bill be amended to clarify that access to data
held in the Register must comply with information-handling requirements as
established in the Privacy Act:
This is because, the purposes of the Register, which are set
out in clause 12 include 'research relating to healthcare, screening or a
designated cancer.' Clause 17 then permits 'certain persons' to collect,
disclose and use 'protected information' (which includes personal information)
for the purposes of the Register. As such, clause 12 together with clause 17,
appear to authorise the use of personal information in the Register for
research purposes without specifically requiring compliance with the s 95
Guidelines or s 95A Guidelines [of the Privacy Act].
Having said that, I acknowledge that the Explanatory
Memorandum to the NCSR Bill does state that where research requires
identifiable information from the Register and it is impracticable to obtain
individuals' consent, researchers will be required to comply with the
guidelines under sections 95, 95A or 95AA of the Privacy Act. However, I
recommend that this requirement be made explicit in the NCSR Bill in order to
provide a clear and unambiguous information-handling requirement.[29]
Direct purposes
2.39
The OAIC further noted that the privacy concerns regarding the Bill
could be improved by tightening the purposes of the Register contained in clause
12. Currently the Bill allows for use of the Register's data for purposes
'incidental' to the specified purposes. The OAIC recommended that the provision
be redrafted to allow use or disclosure only for reasons that are directly
related to the purposes of the Register:
Authorising the information to be handled for any purpose
that is 'incidental' to the other purposes may be too broad and presents a risk
that information may be used or disclosed for more expansive purposes than
initially intended. Therefore, I recommend that the wording of the provision be
narrowed to only allow uses or disclosures that are directly related to the
purposes of the Register. This would also reflect the terminology of the
[Australian Privacy Principles] which limit secondary uses and disclosures of
sensitive information (such as health information) to purposes directly related
to the primary purpose.[30]
Medicare claims information
2.40
Similarly, the OAIC's submission noted some ambiguity in the wording of
the Explanatory Memorandum (EM) around Medicare claims information. While the
Bill itself (in clause 11) states that the Register would contain 'claims
information which may indicate whether or not the individual has undergone or
should undergo screening', the EM outlines broader guidelines that: 'Medicare
claims information of individuals who are within the coverage of the Register
will be collected as part of the establishment and ongoing operation of the
Register'.[31]
2.41
The OAIC recommended that the Bill be redrafted to clarify that only
Medicare claims information related to whether or not the individual has
undergone or should undergo screening will be contained within the Register.[32]
Mandatory breach reporting
2.42
The OAIC also recommended that the Bill's provisions regarding data
breach reporting should be made consistent with those in the My Health Records
Act 2012, which mandates disclosure to affected individuals as well as the
Privacy Commissioner:
The Register operator's security requirements could be
strengthened by requiring the operator to report data breaches and specifying
requirements around the handling of data breaches in a manner consistent with
the data breach requirements in section 75 of the My Health Records Act 2012
(My Health Records Act).
Consistency with the My Health Records Act requirements is
particularly important if the Register will link to the My Health Record system
and if information in the Register will be made available through that system.[33]
Opt-out terminology
2.43
The OAIC also pointed out that there was some ambiguity with the wording
in the Bill's process for individuals removing themselves from the Register,
noting that the phrase 'opt-off', as used in the EM, is inconsistent with other
Commonwealth legislation. This ambiguity could be reduced by amending it to
instead use the phrase 'opt-out', a more consistently used term:
The My Health Record system uses the terminology 'opt-out',
where relevant. Whilst I appreciate that it is the correct use of language to
opt-off a register and opt-out of a system, I see value in describing the
concept of withdrawing participation in both the My Health Record system and
the Register in similar terms. This will ensure that consistent language is
used to explain that individuals have a choice about whether or not to include
their personal information in the Register or the My Health Record system.[34]
2.44
Australian Privacy Commissioner and Acting Information Commissioner Mr
Timothy Pilgrim confirmed that he had no concerns with the opt-off provisions
of the Bill, but noted that a clarification of the terminology, making it
consistent with other legislation, would be a positive step. Mr Pilgrim also
noted that the existence of the provision should be well publicised, ensuring
that people are aware of their options.[35]
Recourse through the OAIC
2.45
A further suggestion from the OAIC is that the Bill could include a
provision classifying a breach of the proposed legislation as an 'interference
with privacy' for the purposes of the Privacy Act. That would ensure that the
OAIC had the power to investigate any such breach.
Departmental response
2.46
The committee notes that the department is 'actively considering' all
six of the OAIC recommendations as summarised below:
- Amend clause 12(1)(n) to expressly require that
research relating to healthcare, screening or a designated cancer comply with
s95, s95A and s95AA of the Privacy Act.
- Amend clause 12(1)(0) to replace 'anything
incidental' with 'anything directly related' or remove this clause altogether.
- Amend sub-clause ll(e) regarding contents of the
Register to make it explicit that collection of Medicare claims information is
limited to screening information for the designated cancers.
- Amend the terminology in the NCSR Explanatory
Memorandum to refer to Opt-out, consistent with the terminology used for the My
Health Record.
- Amend the NCSR Bill to include provision for a
breach of the Bill to constitute interference with privacy for the purpose of
the Privacy Act.
- Amend the NCSR Bill to include a provision requiring
the Register Operator (and others dealing with the Register) to notify breaches
to the Information Commissioner consistent with section 75 of the My Health
Record Act 2012.[36]
Committee view
2.47
Bowel and cervical cancer collectively take the lives of hundreds of
Australians each year. Expanding and updating the existing screening programs
for each will have a marked and significant improvement on Australia's public
health, along with the lives of the individuals it directly affects. The
committee therefore whole-heartedly supports the expansion of these programs
and the establishment of the National Cancer Screening Register.
2.48
While recognising the concerns brought forward by some witnesses
regarding data security and privacy, the committee notes assurances from both
the Department of Health and Telstra Health that they have put in place
appropriate safeguards to ensure that the Register is safe, effective and
maintains Australians' privacy. Telstra Health's outlining of its security
process, including constant monitoring and certification by the ASD,
demonstrates the high standard of security safeguards under which they intend
to keep the Register.
2.49
The committee also notes the many witnesses who emphasise the importance
of the Bills passing Parliament without undue delay and the negative
ramifications if that were not to happen.
Recommendation 1
2.50
The committee recommends that the Government closely consider amending
the National Cancer Screening Register Bill 2016 in line with the
recommendations from the Office of the Australian Information Commissioner.
Recommendation 2
2.51
The committee recommends that the Bills be passed.
Senator Jonathon Duniam
Chair
Navigation: Previous Page | Contents | Next Page